- Home
- SNY vs TXN Comparison
SNY vs TXN Comparison
Compare SNY & TXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- TXN
- Stock Information
- Founded
- SNY 1994
- TXN 1930
- Country
- SNY France
- TXN United States
- Employees
- SNY N/A
- TXN N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- TXN Semiconductors
- Sector
- SNY Health Care
- TXN Technology
- Exchange
- SNY Nasdaq
- TXN Nasdaq
- Market Cap
- SNY 123.6B
- TXN 137.4B
- IPO Year
- SNY N/A
- TXN N/A
- Fundamental
- Price
- SNY $49.90
- TXN $172.27
- Analyst Decision
- SNY Buy
- TXN Hold
- Analyst Count
- SNY 2
- TXN 27
- Target Price
- SNY $62.50
- TXN $192.56
- AVG Volume (30 Days)
- SNY 3.1M
- TXN 8.5M
- Earning Date
- SNY 04-24-2025
- TXN 04-23-2025
- Dividend Yield
- SNY 3.21%
- TXN 3.16%
- EPS Growth
- SNY 39.56
- TXN N/A
- EPS
- SNY 5.45
- TXN 5.28
- Revenue
- SNY $48,817,552,946.00
- TXN $16,049,000,000.00
- Revenue This Year
- SNY $5.35
- TXN $8.84
- Revenue Next Year
- SNY $6.69
- TXN $12.78
- P/E Ratio
- SNY $18.73
- TXN $32.63
- Revenue Growth
- SNY N/A
- TXN N/A
- 52 Week Low
- SNY $45.80
- TXN $139.95
- 52 Week High
- SNY $60.12
- TXN $220.39
- Technical
- Relative Strength Index (RSI)
- SNY 37.47
- TXN 59.13
- Support Level
- SNY $51.67
- TXN $159.11
- Resistance Level
- SNY $55.73
- TXN $166.35
- Average True Range (ATR)
- SNY 0.89
- TXN 3.97
- MACD
- SNY -0.12
- TXN 2.42
- Stochastic Oscillator
- SNY 0.34
- TXN 99.09
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.